Profile | GDS2987 / GI_34335275-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | ||
GSM215244 | HMVEC_vehicle_rep2 | 2.7 | 7 |
GSM215253 | HMVEC_vehicle_rep3 | ||
GSM215254 | HMVEC_atorvastatin_rep1 | 2.4 | 7 |
GSM215282 | HMVEC_atorvastatin_rep3 | 10.6 | 25 |
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 4.3 | 9 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | ||
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | 8.3 | 30 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | 10.5 | 18 |
GSM215297 | PASMC_vehicle_rep1 | 97.1 | 73 |
GSM215298 | PASMC_vehicle_rep2 | 90.9 | 72 |
GSM215310 | PASMC_vehicle_rep3 | 55.5 | 63 |
GSM215311 | PASMC_atorvastatin_rep1 | 155.9 | 79 |
GSM215312 | PASMC_atorvastatin_rep2 | 121.5 | 76 |
GSM215313 | PASMC_atorvastatin_rep3 | 171.4 | 79 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 153.8 | 78 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 86.4 | 73 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 76.5 | 71 |
GSM215327 | PASMC_SLx2119_rep1 | 137.4 | 77 |
GSM215328 | PASMC_SLx2119_rep2 | 118.9 | 76 |
GSM215329 | PASMC_SLx2119_rep3 | 143.8 | 78 |
GSM215330 | Fibroblasts_vehicle_rep1 | 24.9 | 49 |
GSM215331 | Fibroblasts_vehicle_rep2 | 37.2 | 64 |
GSM215332 | Fibroblasts_vehicle_rep3 | 16.9 | 48 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 36 | 63 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 7 | 20 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 11.8 | 29 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 37.5 | 66 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 24.7 | 58 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 42.7 | 67 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 27.1 | 58 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 8.4 | 23 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 16.5 | 39 |